Chen Y, Peng X, Feng Z, Zhang L, Bai J, Li Y, et al
Water, Methylpropanediol, Ascorbic Acid, Propylene Glycol, Polysorbate 20, Glycerin, Laureth-23, Ethoxydiglycol, Kojic Acid, Niacinamide, Phenoxyethanol, Alpha-Arbutin, Citrus Aurantium Dulcis (Orange) Peel Oil, Ferulic Acid, Tocopherol, Triethanolamine, Azelaic Acid, Butylene Glycol, Panthenol Glutathione, Retinyl Palmitate, Camellia Sinensis Leaf Extract, Euterpe Oleracea Fruit Extract, Sodium Hyaluronate, Diethanolamine
While these findings have not been linked to serious adverse outcomes so far, they highlight the need for long-term safety studies, which are currently underway in Phase 3 trials
Moreover, GSAAT(C190S) also appears to be less stable than the other CS substitution mutants ( Supplementary Figure 3D )
Description Details Dosage Research Questions BPC-157 BPC-157 is supplied for laboratory research workflows that require clear product identity, careful handling, and documented specifications
Definitions of all these variables using administrative claims are described in Additional file 1: Table S1